Sign In

Login

Password

Forgot Password ? Sign Up

اوتامیکسابان (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "اوتامیکسابان" in Persian language version.

refsWebsite
Global rank Persian rank
1ingenta.com
low place
2,600th place
1doi.org
2nd place
2nd place
1nih.gov
4th place
5th place
1archive.org
6th place
9th place
1rttnews.com
9,290th place
low place

archive.org

  • "AstraZeneca, Sanofi Cut Programs". Chemical & Engineering News. American Chemical Society. 91 (23): 17. June 10, 2013. Sanofi is ending development on two compounds, the anticancer compound iniparib and the anticoagulant otamixaban, both of which flunked Phase III studies.

doi.org

  • Guertin KR, Choi YM (2007). "The discovery of the Factor Xa inhibitor otamixaban: from lead identification to clinical development". Curr. Med. Chem. 14 (23): 2471–81. doi:10.2174/092986707782023659. PMID 17979700.

ingenta.com

openurl.ingenta.com

  • Guertin KR, Choi YM (2007). "The discovery of the Factor Xa inhibitor otamixaban: from lead identification to clinical development". Curr. Med. Chem. 14 (23): 2471–81. doi:10.2174/092986707782023659. PMID 17979700.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Guertin KR, Choi YM (2007). "The discovery of the Factor Xa inhibitor otamixaban: from lead identification to clinical development". Curr. Med. Chem. 14 (23): 2471–81. doi:10.2174/092986707782023659. PMID 17979700.

rttnews.com